{"database": "openregs", "table": "federal_register", "rows": [["2010-207", "Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium", "Rule", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. The supplemental NADA provides for a revised human food safety warning for use of hyaluronate sodium injectable solution in horses.", "2010-01-11", 2010, 1, "https://www.federalregister.gov/documents/2010/01/11/2010-207/implantation-or-injectable-dosage-form-new-animal-drugs-hyaluronate-sodium", "https://www.govinfo.gov/content/pkg/FR-2010-01-11/pdf/2010-207.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. The supplemental NADA provides for a revised human food safety...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2010-207"], "units": {}, "query_ms": 27.0631070015952, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}